PharmaSens Unveils First All-in-One Insulin Patch Pump: A Step Toward Simpler Diabetes Care

PharmaSens Unveils First All-in-One Insulin Patch Pump: A Step Toward Simpler Diabetes Care

By, Admin 11 April 2026

Diabetes tech is powerful—but still too complicated. Multiple devices. Connectivity issues. High costs. Now, PharmaSens AG is trying to collapse that complexity into a single wearable. And for the first time, clinical data suggests it’s actually possible.

The Breakthrough: One Device, Two Critical Functions

niia insulin patch pump combines:

  • Insulin delivery
  • Continuous glucose monitoring (CGM)

…into a single, discreet patch worn on the body.

Why This Matters?

Today’s “automated insulin delivery (AID)” systems require:

  • A separate insulin pump
  • A separate CGM
  • Software to connect them

This creates friction. The niia device removes that friction by integrating everything into one system.

The Study: First Clinical Proof of Feasibility

The findings, published in the Journal of Diabetes Science and Technology, mark the first clinical evidence that this concept works.

Trial Snapshot

  • 18 adults with Type 1 diabetes
  • 72-hour wear period (main phase)
  • Real-world testing with meals and daily activity

Participants still used the Dexcom G6 CGM System for treatment decisions (for safety), but the investigational device collected performance data.

Key Results: Promising Early Signals

Accuracy

  • MARD: 11.6%
    • (Target for ideal CGMs: <10%)
  • 83% readings in clinically accurate Zone A
  • 100% within acceptable Zones A + B

Reliability

  • Zero insulin delivery failures
  • No adverse events reported

Translation

  • Accuracy is close to commercial-grade CGMs
  • Safety profile looks strong
  • Integration is technically feasible

The Real Problem It Solves

Despite strong outcomes, adoption of advanced diabetes tech remains low.

The Gap

  • ~11 million intensive insulin users (US + Europe)
  • Only ~13% use automated systems

Why?

  • Device complexity
  • Cost barriers
  • User fatigue

Why “All-in-One” Changes the Game

A fully integrated device could:

  • Reduce daily management burden
  • Eliminate device syncing issues
  • Lower total cost of care
  • Improve treatment adherence

In short: Less effort → better outcomes

Backed by Clinical Direction

The American Diabetes Association already recommends automated insulin delivery systems as the preferred standard for:

  • Type 1 diabetes
  • Intensive insulin-treated Type 2 diabetes

But current systems are still too complex. PharmaSens is aiming to fix that last mile.

What’s Next: Next-Gen Device Already in Progress

PharmaSens isn’t stopping here.

Upcoming Plans

  • Second feasibility study in Q2 2026
  • Next-gen device integrating:
    • Proprietary niia platform
    • Advanced CGM tech from SiBionics

This could push accuracy closer to—or beyond—current CGM standards.

The Bigger Trend: Simplifying Chronic Care

Healthcare innovation is shifting from:

  • More features
    → to
  • Less friction

Especially in chronic diseases like diabetes, where:

  • Daily adherence determines outcomes
  • Simplicity drives real-world success

Final Take

This is still early-stage.  But it’s a meaningful proof point. PharmaSens AG has shown that:

  • Integrated insulin delivery + glucose sensing
  • In a single wearable device
  • With acceptable accuracy and safety

…is no longer theoretical.

If future studies validate and improve this, the niia system could become a category-defining shift in diabetes management, not by adding more tech, but by removing complexity altogether.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!